141 related articles for article (PubMed ID: 26551618)
1. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
Paquette C; Mills AM; Stoler MH
Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
3. p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary.
Huang EC; Tomic MM; Hanamornroongruang S; Meserve EE; Herfs M; Crum CP
Mod Pathol; 2016 Dec; 29(12):1501-1510. PubMed ID: 27515495
[TBL] [Abstract][Full Text] [Related]
4. CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.
Mills AM; Paquette C; Terzic T; Castle PE; Stoler MH
Am J Surg Pathol; 2017 Feb; 41(2):143-152. PubMed ID: 27680604
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
6. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.
Herfs M; Parra-Herran C; Howitt BE; Laury AR; Nucci MR; Feldman S; Jimenez CA; McKeon FD; Xian W; Crum CP
Am J Surg Pathol; 2013 Sep; 37(9):1311-8. PubMed ID: 24076771
[TBL] [Abstract][Full Text] [Related]
7. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
8. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
9. A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin.
Hong SA; Yoo SH; Choi J; Robboy SJ; Kim KR
Arch Pathol Lab Med; 2018 Aug; 142(8):973-981. PubMed ID: 29652189
[TBL] [Abstract][Full Text] [Related]
10. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.
Sagasta A; Castillo P; Saco A; Torné A; Esteve R; Marimon L; Ordi J; Del Pino M
Mod Pathol; 2016 Jan; 29(1):51-9. PubMed ID: 26541274
[TBL] [Abstract][Full Text] [Related]
11. Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
Umphress B; Sanchez B; Paintal A; Nayar R; Maniar KP
Am J Surg Pathol; 2018 Apr; 42(4):479-484. PubMed ID: 29438168
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.
Lee H; Lee H; Cho YK
Diagn Pathol; 2017 Feb; 12(1):18. PubMed ID: 28212672
[TBL] [Abstract][Full Text] [Related]
13. AgNOR Pleomorphic Count as a Tumor Marker in Cervical Carcinogenesis and Feasibility of Its Introduction in Cervical Cancer Screening Programs to Discriminate High-Risk Cases of Squamous Intraepithelial Lesions of the Cervix.
Srivastava AN; Misra JS; Singh U; Khan M; Raza S
Acta Cytol; 2019; 63(5):371-378. PubMed ID: 31067531
[TBL] [Abstract][Full Text] [Related]
14. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
15. Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker.
Escobar-Hoyos LF; Yang J; Zhu J; Cavallo JA; Zhai H; Burke S; Koller A; Chen EI; Shroyer KR
Mod Pathol; 2014 Apr; 27(4):621-30. PubMed ID: 24051697
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of p16
Miralpeix E; Genovés J; Maria Solé-Sedeño J; Mancebo G; Lloveras B; Bellosillo B; Alameda F; Carreras R
Mod Pathol; 2017 Feb; 30(2):304-310. PubMed ID: 27739439
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
[TBL] [Abstract][Full Text] [Related]
18. Three-Tiered versus Two-Tiered Classification of Squamous Dysplasia in Cervical Cytology: Results of a Follow-Up Study.
Marquardt K; Ziemke P; Neumann K
Acta Cytol; 2019; 63(1):44-49. PubMed ID: 30517915
[TBL] [Abstract][Full Text] [Related]
19. HPV E6/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL).
Mills AM; Coppock JD; Willis BC; Stoler MH
Am J Surg Pathol; 2018 Feb; 42(2):192-200. PubMed ID: 29112014
[TBL] [Abstract][Full Text] [Related]
20. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
